Novogen

a number of images from an MRI scan of the brain
Biotech

Kazia dropped from global umbrella trial to treat brain cancer

Kazia Therapeutics has been dropped from a global adaptive clinical trial looking to find new treatments for an aggressive form of brain cancer.
Max Bayer Aug 1, 2022 1:45pm
Roche HQ

Roche licenses out PI3K pathway brain cancer med to Oz biotech

Oct 31, 2016 6:56am